... communica- tion and AR treatment. Funding: GlaxoSmithKline. J ALLERGY CLIN IMMUNOL. VOLUME 119, NUMBER 1. Abstracts S159. SUNDAY.
Abstracts S159
J ALLERGY CLIN IMMUNOL VOLUME 119, NUMBER 1
Clinical Features and Outcomes of Peanut-Allergic Patients Who Underwent Follow-up Oral Food Challenges J. M. Maloney, W. G. Shreffler, S. H. Sicherer, H. A. Sampson; Mount Sinai Medical Center, New York, NY. RATIONALE: Peanut allergy affects 0.8% of American children and is reportedly ‘‘outgrown’’ in approximately 20%. The purpose of this study was to identify clinical and laboratory features that predict which patients will develop tolerance. METHODS: Patients followed prospectively with suspected peanut allergy (median age 6 yrs; range 3-37 yrs) and low serum peanut-specific IgE levels (median peanut-specific IgE 0.85, range
